Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Breeze Meds

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Breeze Meds head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 62 · Grade C

Breeze Meds

Visit Breeze Meds Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 76 on our six-factor Brief Score — One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

That doesn't make Breeze Meds a bad call — it's best for readers starting at a low dose who want nothing charged until a provider has approved them. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
70
Supply Reliability
95
82
Transparency
90
60
Access Breadth
93
88
Clinical Oversight
92
78
Track Record
88
76
CoreAge RxBrief Score 94 · 76Breeze Meds

Price, coverage & the tracker

CoreAge RxBreeze Meds
Brief Score94/100 (A)76/100 (C)
Semaglutide$99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published$199/mo injectable (list $249) · $299/mo oral — the 3- and 6-month bundles cost MORE per month ($249 and $208); only the 12-month prepay is lower, at $191.50 ($2,298)
Tirzepatide$149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published$299/mo injectable (list $399) · $399/mo oral — the 3- and 6-month bundles cost MORE per month ($356 and $320); the 12-month prepay is $291.50 ($3,498)
CoverageUS only; restrictions by state, confirmed at intakeAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
On the trackerStableprice stableStableprice stable

CoreAge Rx: Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.

Breeze Meds: Every published figure is quoted at the LOWEST dose — the funnel says higher doses may cost more, so these are floors.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.